1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination) | Trials (efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination) | Recent Studies (post-2010) (efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 73 | 12 | 44 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulou, S; Chini, M; Demopoulos, CA; Fragopoulou, E; Gargalianos, P; Lazanas, MC; Mangafas, N; Papakonstantinou, VD; Tsogas, N; Tsoupras, AB | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination
| Article | Year |
|---|---|
Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen.
Topics: Adenine; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Deoxycytidine; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Male; Organophosphonates; Oxazines; Platelet Activating Factor; Viral Load | 2012 |